Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Total Liabilities: 2019-2025

Historic Total Liabilities for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to $116.0 million.

  • CureVac N.V's Total Liabilities fell 40.24% to $116.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $553.0 million, marking a year-over-year decrease of 44.32%. This contributed to the annual value of $113.5 million for FY2024, which is 61.12% down from last year.
  • CureVac N.V's Total Liabilities amounted to $116.0 million in Q2 2025, which was up 15.42% from $100.5 million recorded in Q1 2025.
  • CureVac N.V's Total Liabilities' 5-year high stood at $1.2 billion during Q2 2021, with a 5-year trough of $100.5 million in Q1 2025.
  • In the last 3 years, CureVac N.V's Total Liabilities had a median value of $227.9 million in 2023 and averaged $203.7 million.
  • Per our database at Business Quant, CureVac N.V's Total Liabilities spiked by 374,912.49% in 2021 and then slumped by 74.78% in 2022.
  • Over the past 5 years, CureVac N.V's Total Liabilities (Quarterly) stood at $537.4 million in 2021, then slumped by 37.88% to $333.8 million in 2022, then decreased by 12.56% to $291.9 million in 2023, then crashed by 61.12% to $113.5 million in 2024, then plummeted by 40.24% to $116.0 million in 2025.
  • Its Total Liabilities stands at $116.0 million for Q2 2025, versus $100.5 million for Q1 2025 and $113.5 million for Q4 2024.